Autobahn Therapeutics Highlights New Preclinical Data on Elunetirom Autobahn Therapeutics, a pioneering biotechnology company focused on restorative treatments for neuropsychiatric and neuroimmunologic disorders, announced new preclinical findings for elunetir… at the American College of Neuropsychopharmacology (ACNP) annual meeting. The presentation contributes to growing evidence that elunetirom could drive restorative neuroplasticity, a therapeutic paradigm aimed at…